822
Views
24
CrossRef citations to date
0
Altmetric
Review

Psychological interventions in the management of common skin conditions

Pages 51-63 | Published online: 26 Mar 2010

Abstract

The nervous system and the skin develop next to each other in the embryo and remain intimately interconnected and interactive throughout life. The nervous system can influence skin conditions through psychoneuroimmunoendocrine mechanisms and through behaviors. Understanding the pathophysiology aids in selection of treatment plans for correcting the negative effects of the psyche on specific skin conditions. Medication options include standard psychotropic medications and alternative herbs and supplements. Other options include biofeedback, cognitive-behavioral methods, hypnosis, meditation, progressive relaxation, the placebo effect, and suggestion. When simple measures fail, combining medications with other therapeutic options may produce better results. Skin conditions that have strong psychophysiologic aspects may respond well to techniques such as biofeedback, cognitive-behavioral methods, hypnosis, meditation, or progressive relaxation that help to counteract stress. Treatment of primary psychiatric disorders that negatively influence skin conditions often results in improvement of those skin conditions. Abnormal conditions of the skin, hair, and nails can also influence the psyche negatively. Treatment of secondary psychiatric disorders such as anxiety or depression that are triggered or exacerbated by the appearance of these skin conditions or the associated discomfort may also be required.

Overview of psychocutaneous disorders

The nervous system and the skin begin to form and develop side by side in the top layer or ectoderm of the fetus and remain intimately interconnected and interactive throughout life. The neural receptors in the skin may be viewed as the largest sense organ of the body and are key to skin protection and health. Many skin disorders have a significant psychosomatic or behavioral element.Citation1 Nervous system-skin interactions allow drug and non-drug psychotherapeutic interventions that produce positive effects on many cutaneous diseases. These effects occur through actions of drugs, the autonomic nervous system, local hormones, and neuropeptides, resulting in neurogenic modulation of cutaneous inflammation.Citation2 The skin is also affected by brain-regulated behavioral habits which alter exposure to various environmental factors such as sun exposure, and occupational and recreational exposures to animals, plants, and chemicals, and climate changes associated with travel. Skin disorders often have negative effects on the patient’s psychological and social status. Drug and non-drug interventions may help ameliorate the negative effects of the skin disorder on the psyche.Citation3 A combined approach using both drug and non-drug methods is often needed when treating complex cutaneous psychosomatic and somatopsychosocial problems. Patients who are referred by a dermatologist or family physician to a psychiatrist or psychologist often refuse the referral or fail to keep the appointment. Few dermatologists are adequately cross-trained in psychiatry or psychology. A recent review of psychodermatology covered the relevant literature from 1951 to 2004.Citation4 The development of subspecialty training in psychodermatology is currently being considered.Citation5 How important the psychosocial aspects of skin, hair, and nails are to many individuals is reflected in the large amount of money spent on skin, hair, and nail products, and on cosmetic skin procedures.

Skin disorders with psychophysiologic aspects

Stress and emotion

Inflammatory and sensory skin disorders are significantly influenced by stress and emotion. Griesemer, who trained both as a dermatologist and as a psychiatrist, estimated the effect that emotions had on skin disease for each patient he saw during one year in his practice. From these data he developed an indexCitation6 of the effects of emotions on specific skin disorders.Citation7 The pathways by which stress and emotion affect the nervous system, immune system, and hormonal system and their subsequent effects on inflammation and autonomic functioning and on the skin are still being elucidated. Citation8 Stress can induce or exacerbate anxiety disorders or depression in susceptible individuals. Drugs that reduce anxiety or depression can be helpful in those individuals. No direct anti-stress drug had yet been developed. The non-drug modalities of relaxation, biofeedback, meditation, or self-hypnosis can counteract stress and emotion.Citation9 Simple inexpensive temperature-sensitive stress cards can be used to promote hand warming, which is associated with relaxation.Citation10 Heart rate variability (HRV) biofeedback accompanied by slower deeper breathing can also reduce the effects of stress and emotion.Citation11 Compact, highly portable, handheld HRV biofeedback devices such as the HeartMath emWave® personal stress reliever and the StressEraser® have recently become available.

Stress and emotion reduction in skin conditions

Inflammatory, immune-mediated, and behavioral skin disorders are influenced by psychosomatic factors.Citation12 In a recent study, 10% of patients at a dermatology clinic had psychosomatic disorders and another 15% had adjustment disorders.Citation13 In conjunction with other appropriate treatments for the skin disorders, reducing stress, emotions, and behavioral habits that impair healing or damage to skin, hair, or nails can enhance response to treatment. Associated anxiety or depression can be treated with anxiolytic drugs or antidepressants.Citation14 Non-drug methods of stress reduction such as relaxation, meditation, self-hypnosis, physical exercise, or biofeedback can directly counteract the stress.

Acne

Acne vulgaris often flares with stress and premenstrually.Citation15 With worsening of the acne, many individuals get more stressed, setting up a vicious cycle. Conventional acne treatments can help control the acne, reducing the patient’s stress about having the acne. Stress may also be lessened with relaxation training Citation16 or another of the above-mentioned methods.

Alopecia areata

Alopecia areata usually occurs as patchy bald spots where immune dysregulation results in the hair follicles being attacked by inflammatory T-lymphocytes. Alexithymia with difficulty recognizing and describing feelings and dissociative somatization has been reported to be more common in adults with alopecia areata than in controls.Citation17 Stress can initiate or worsen alopecia areata.Citation18 The hair loss can aggravate the stress, especially if the hair loss is visible to others. Self-image issues and stress may be treated with self-hypnosisCitation19 or another of the aforementioned methods.

Atopic dermatitis

Atopic dermatitis is produced mainly by scratching and flares with stress though psychoneuroimmunomechanisms. Citation20 Worsening atopic dermatitis can further stress the patient, who then tends to scratch more and further worsen the dermatitis. Stress may be lessened with cognitive-behavioral methods,Citation21 hypnosis or self-hypnosis,Citation22 or another of the above-mentioned methods. If indicated, adjunctive anxiolytic drugs or antidepressants may be employed.

Dermatitis artifacta

Self-induced factitial damage to the skin often occurs in odd otherwise unexplainable forms and may indicate a seriously disturbed patient or may occur for secondary gain.Citation23 Consultation with a psychiatrist or psychologist is recommended. Often the patient denies self-inflicting the trauma and frequently is noncompliant in obtaining a psychiatric evaluation.

Dyshidrosis

Dyshidrosis consisting of tiny blisters on palms and/or soles typically flares with stress.Citation6 In addition to conventional topical treatments, stress reduction can be of benefit. Stress may be reduced by HRV biofeedback, or galvanic skin response (GSR) biofeedbackCitation24 or another of the above-mentioned methods.

Erythema nodosum

Erythema nodosum with deep painful red nodules on the legs may worsen with stress. The author has reported a case of resolution of intractable erythema nodosum following hypnoanalysis.Citation25

Herpes simplex

Stress frequently initiates or exacerbates herpes simplex cold sore virus recurrences.Citation26 Along with using conventional antiviral treatments for the herpes, stress reduction may be facilitated with self-hypnosisCitation27 or another of the aforementioned methods.

Hyperhidrosis

Hyperhidrosis of hands, feet, axillae, or forehead has a clear rapid onset correlation with stress.Citation6 Locally injected botulinum toxin (Botox®) can temporarily inactivate acetylcholine release from the nerves associated with sweating.Citation28 Stress may be reduced with GSR biofeedback, or HRV biofeedbackCitation29 or another of the above-mentioned methods.

Lichen planus

Lichen planus, an inflammatory pruritic dermatosis, is often triggered or exacerbated by stress. The intense itching and discoloration with hyperpigmentation that typically occur with lichen planus can further fuel the stress. As an indicator of stress, elevated salivary cortisol levels have been detected in patients with oral lichen planus.Citation30 The stress may be reduced using self-hypnosisCitation27 or another of the aforementioned methods.

Lichen simplex chronicus

Thickened plaques of lichen simplex chronicus are produced by rubbing or scratching the skin and are initiated or exacerbated by stress. In some cases, dissociation with somatization may play a role.Citation31 Along with standard topical treatments, stress reduction can be beneficial. The stress may be reduced with self-hypnosisCitation27 or another of the above- mentioned methods.

Neurotic excoriations

Neurotic excoriations are skin damage self-induced by scratching,Citation32 and neurotic or psychogenic excoriations are worsened by stress. The stress may be lessened with self-hypnosisCitation33 or another of the aforementioned methods. The commonly associated anxiety or depression may be treated with adjunctive anxiolytic drugs or antidepressants.

Nummular dermatitis

Nummular dermatitis consists of coin-shaped patches on dry areas of skin and in some individuals can flare with stress. Connections of nerves to mast cells have been noted in the basement membrane zone in nummular dermatitis.Citation34 Along with standard topical treatments, stress reduction can be helpful. The stress may be reduced using self-hypnosisCitation27 or another of the above-mentioned methods.

Perioral dermatitis

Perioral dermatitis, similar to acne but located around the mouth, can be exacerbated by stress or other neurogenic factors.Citation35 Along with conventional topical treatments, stress reduction can be useful. The stress may be reduced with self-hypnosisCitation27 or another of the aforementioned methods.

Pruritus

Pruritus or itching is frequently worsened by stress. Many inflammatory skin diseases are itchy via neuroimmunoendocrine mechanisms.Citation36 See later under neurogenic cutaneous sensory dysesthesias for further discussion of pruritus and its treatment. Stress reduction can be helpful. The stress may be lessened with self-hypnosisCitation27 or another of the above-mentioned methods.

Psoriasis

Psoriasis in many patients flares with stress.Citation37 Along with standard treatments, stress reduction can help reduce flares. Many patients are distressed by the disfigurement of the skin by the psoriatic lesions. Alexithymia with dissociative somatization can aggravate psoriasis and has a higher risk of associated alcoholism.Citation38 Body image issues and stress and may be improved with cognitive-behavioral methods,Citation39 biofeedback, meditation,Citation40 relaxation training, or self-hypnosis.Citation41

Rosacea

With rosacea the facial flushing and the papular inflammations both can flare with stress.Citation42 Many rosacea patients are in turn distressed by their facial appearance. Stress may be reduced with self-hypnosisCitation27 or another of the above-mentioned methods.

Seborrheic dermatitis

Stress frequently worsens the scaling and itching of seborrheic dermatitis.Citation36 In addition to conventional treatments for the seborrheic dermatitis, stress may be reduced using self-hypnosisCitation27 or another of the aforementioned methods.

Telogen effluvium

Telogen effluvium is diffuse hair loss and may be acute or chronic. Common initiators are stress, low protein intake, and hormonal changes.Citation43 Stress may be reduced with one of the above mentioned methods. Any accompanying depression may be treated with an antidepressant.Citation14

Trichotillomania

Stress can worsen the repetitive pulling and twisting behavior that produces trichotillomania.Citation44 Reducing stress may be accomplished with self-hypnosisCitation45 or another of the aforementioned methods.

Urticaria

Urticaria or hives may be triggered or exacerbated by stress.Citation36 The itchy urticaria can in itself be stressful, creating a vicious circle. Stress may be reduced with self-hypnosisCitation46 or another of the above-mentioned methods.

Influence of primary psychiatric disorders on skin diseases

Primary anxiety

Acute or chronic anxiety can worsen many skin disorders. Having a skin disorder can also induce anxiety in susceptible individuals. In a recent study, 13% of patients seen at a dermatology clinic had an anxiety disorder.Citation13

Psychogenic pruritus

Psychogenic pruritus or itching initiated or exacerbated by anxiety or psychological trauma or stress should be considered when other causes of pruritus have been ruled out.Citation34 Stress and anxiety may be lessened using self-hypnosisCitation27 or another of the above-mentioned methods. Anxiety may also be treated with anxiolytics.Citation14

Delusions

Delusions of parasitosis

Delusions of parasitosis occur when the patient insists that they have bugs growing in or on their skin when objectively they do not. This is one of the monomaniacal delusions. Compliant patients generally respond to typical antipsychotics such as pimozide or atypical antipsychotics such as olanzapine or risperidone. Parenterally administered risperidone was found to be particularly effective, since this route of administration had built-in monitoring of compliance.Citation47

Primary depression

Depression and risk of self-harm or suicide can occur as a primary process or secondary to a skin disease. Primary depression may also be associated with acts that self-harm the skin such as scratching, picking, digging, burning, cutting, pulling, tearing, or otherwise harming the skin, hair, or nails.Citation48 In a recent study, 32% of patients seen at a dermatology clinic had depression.Citation13 The majority of patients who have self-inflicted dermatoses such as neurotic or psychogenic excoriations suffer from depression with somatization.Citation49 Treating the depression with an antidepressantCitation14 may help to reduce or eliminate the self-damaging habit.

Impulse control

Acne excoriée

Some patients who pick at their acne excessively are primarily impulsive in their picking. Along with standard treatments for the acne, reducing or stopping the picking habit is necessary. Cognitive–behavioral methods or hypnosis and self-hypnosisCitation50 may be used. If these measures fail, hypnoanalysis may be considered.

Neurodermatitis

Some neurodermatitis patients are primarily impulsive in their picking.Citation51 Cognitive–behavioral methodsCitation52 or hypnosis and self-hypnosisCitation27 may be of benefit. For resistant cases, hypnoanalysis may be employed.

Trichotillomania

Trichotillomania is currently classified as an impulse control disorder.Citation44 Cognitive-behavioral methods may be beneficial.Citation53 Hypnoanalysis may help deal with root causes in refractory cases.

Obsessive–compulsive disorder

Obsessive–compulsive disorder spectrum patterns may be a primary factor in producing skin disease or in exacerbating a pre-existing skin disease such as acne, atopic dermatitis, or psoriasis. In a recent study, about 5% of patients evaluated at a dermatology clinic had obsessive–compulsive disorder.Citation13

Acne excoriée

Some acne excoriators are primarily obsessive–compulsive in their picking.Citation50 Cognitive-behavioral methods may be helpful, as may selective serotonin reuptake inhibitor (SSRI) antidepressants.Citation54 Hypnosis with pattern-interrupt suggestions may also be of benefit.

Onychotillomania

Onychotillomania is compulsive manipulation causing damage to nails. It may be a form of obsessive–compulsive disorder. Citation55 Cognitive-behavioral methods may be of benefit, as may SSRI antidepressants.Citation54 Hypnosis with pattern-interrupt suggestions may also help.

Neurodermatitis

Some patients with neurodermatitis or psychogenic excoriations fit best into the obsessive–compulsive category.Citation49 Cognitive-behavioral methods may be of benefit, as may SSRI antidepressants.Citation54 In some patients, hypnosis with pattern-interrupt suggestions may be effective. In unresponsive cases, hypnoanalysis may be considered.

Somatization with dissociation

Unexplainable bodily symptoms that have no underlying physical pathology are common both in general medicine and in dermatology. Common somatization with dissociation syndromes in general medicine include chronic fatigue syndrome, fibromyalgia, irritable bowel syndrome, and interstitial cystitis.Citation56 In dermatology, somatization with dissociation syndromes include unexplained cutaneous sensory syndromes (see below), body memories from traumatic stress in post traumatic stress syndrome (PTSD) that manifest as pruritus, urticaria, or angioedema, self-induced dermatitis artifacta and trichotillomania associated with dissociative states, and body dysmorphic disorder, where the patient has a distorted somatic preoccupation involving the skin or hair.Citation49 Among acne patients, 14% to 21% have aspects of body dysmorphic disorder.Citation57 Nihilodermia refers to problem patients without objective skin findings but who have recurrent symptoms and are insistent on medical examination and treatment.Citation58 Alexithymia is associated with somatization with dissociation and is characterized by difficulty in recognizing and describing feelings.Citation59 As a general rule, functional somatic syndromes seem more responsive to active non-drug treatments requiring active patient participation, such as exercise and psychotherapy compared with passive physical procedures and injections. Also, drugs that have a central nervous system action generally are more effective than those that affect peripheral physiologic function. Citation60 If antidepressant treatment alone is ineffective, adding pregabalin may result in improvement.Citation61

Neurogenic cutaneous sensory dysesthesias

Dysesthesias arising in the central nervous system

Generalized pruritus or itching without any visible skin eruption can be due to metabolic, renal, thyroid, hematologic, and other internal diseases. After ruling these out, central nervous system dysfunction as the source of neurogenic pruritus should be considered. One example is pruritus associated with neurotic excoriations.Citation62 Another example is otherwise unexplained pruritus associated with somatization with dissociation. Citation63 Sedating antihistamines such as hydroxyzine or doxepin have some antipruritic effect, as may some opiate agonists, but for neurogenic pruritus there is no really potent antipruritic drug.

Dysesthesias arising in the peripheral nervous system

Brachioradial pruritus

Brachioradial pruritus or itching of the arm, antecubital fossa, and proximal forearm tends to occur in lightly pigmented individuals who have had extensive chronic sun exposure.Citation64 This generally is more prominent during the summer. In some patients, peripheral neuropathic pruritus associated with cervical spinal foramen nerve impingement may be the etiologic factor.Citation65 Relief from the pruritus may be obtained by sun protection, topical menthol, topical capsaicin, or oral gabapentin.

Glossodynia

After organic factors for tongue pain such as vitamin deficiency are ruled out, treatment of glossodynia is symptomatic with topical anesthetics. In some cases, oral gabapentin or oral olanzapine may be useful.Citation66

Notalgia paresthetica

Notalgia paresthetica is a peripheral neuropathic pruritus of the medial subscapular shoulder blade area that, at least in some cases, may relate to nerve impingement in a thoracic spinal foramen.Citation67 The topical antipruritics, menthol or capsaicin, may offer relief, as may oral gabapentin.Citation67

Postherpetic neuralgia

Postherpetic neuralgia is a peripheral neuropathic pruritus, pain, or paraesthesia following herpes zoster (shingles). It occurs more frequently in individuals older that 60. Topical treatment with capsaicin four or five times a day, which depletes substance P in the nerves, may be useful. Oral gabapentin also may help reduce the neuropathic sensations. Citation68 Acupuncture and hypnosisCitation27 for pain or pruritus have provided relief in some patients.

Pruritus ani, pruritus scroti, and pruritus vulvae

Organic factors such as pinworms, candidal and fungal infections, and inflammatory skin diseases should be ruled out first. The source of the pruritus ani, pruritus scroti, or pruritus vulvae may be peripheral neuropathic as a result of sacral nerve impingementCitation69 or may be psychogenic. Topical pramoxine and hydrocortisone may offer relief for some patients. Oral antihistamines may benefit some patients.Citation70

Secondary psychiatric disorders associated with skin diseases

Around 30% of patients with skin disorders are reported to have psychiatric disorders and psychosocial impairments.Citation71 The overall prevalence of psychological disorders among patients with skin disease is about 25% to 30%, but even higher prevalence rates, above 30%, occur among patients with acne, alopecia, herpes simplex pruritus, and urticaria.Citation72 Skin disease with associated psychological morbidity results in poorer quality of life than just having the skin disease alone.Citation73

Secondary anxiety

Acne

In susceptible individuals, acne can lower self-esteem, self-confidence, cause embarrassment, and impair social functioning. In anxiety-prone individuals, acne can also increase anxiety substantially. The added stress and anxiety can cause acne to flare, creating a vicious cycle.Citation74 Drug treatments for anxiety include a low-dose benzodiazepine monitored carefully, buspirone, or herbal anxiolytics, such as magnolia bark or passion flower. Relaxation techniques, self-hypnosis, or biofeedback for relaxation can enhance treatment of anxiety without the side effects of drugs.

Urticaria

Urticaria or hives with release of pruritus-inducing histamine can induce anxiety in anxiety-prone individuals. The anxiety can in turn flare the urticaria, creating a vicious cycle.Citation36 The antihistamines diphenhydramine, doxepin, and hydroxyzine are sedating and can reduce anxiety while also reducing the urticaria through their antihistaminic effect.

Secondary depression

For each of the conditions below, patients with major depression should be referred to a psychiatrist for care. SSRIs or tricyclics may be prescribed for minor depression,Citation14 or the herb St. John’s wort may be recommended. Cognitive-behavioral therapy may also be helpful for depression.

Acne

Acne usually begins in puberty in conjunction with sex hormone changes. Adolescent patients with severe acne had a prevalence of depression of about 18% to 29%, compared with a prevalence of depression of about 5% to 8% for the general adolescent population.Citation75 Depressive symptoms are often concealed, denied or expressed through aggressive or disruptive behavior in adolescents. A more severe form of acne, nodulocystic acne, often persists late into adulthood. Oral isotretinoin used to treat nodulocystic acne has been questionably associated with increased depression and suicide.Citation76

Alopecia

Hair loss may occur with androgenetic (male pattern) alopecia, alopecia areata (patchy hair loss), scarring from discoid lupus or lichen planopilaris, telogen effluvium (diffuse hair loss), hypothyroidism, as a side effects of drugs, especially cancer chemotherapy drugs, or as a result of behavior such as trichotillomania or traction alopecia. Hair appearance can affect psychosocial functioning. In susceptible individuals, hair loss can induce or exacerbate depression. Alopecia areata can worsen with depression.Citation16

Atopic dermatitis

The pruritus or itching of atopic dermatitis can aggravate depression in depression-prone individuals, who then often scratch more and worsen their skin disorder.Citation77 The antihistamines diphenhydramine, hydroxyzine, and doxepin cause sedation and can reduce pruritus and scratching through their antihistaminic effect. Doxepin is also a tricyclic antidepressant. Individuals with major depression should be referred to a psychiatrist for care. Self-hypnosis with suggestions for soothing can reduce pruritus or itching and give the patient a sense of greater control, which in turn can improve the depression.

Disfigurement

Disfigurement secondary to skin disorders, traumatic injuries, Citation78 and surgeries for skin cancers can aggravate depression in depression-prone individuals. Hypnosis and reframing can alter the patient’s perspective on their disfigurement, secondarily reducing depression.

Malignant melanoma

Metastatic melanoma often has a grim prognosis and can induce situational depression, which in turn degrades the body’s immune responseCitation79 against the melanoma metastases. Treatment of the depression may enhance the body’s ability to respond against the melanoma.

Psoriasis

In depression-prone individuals, psoriasis can initiate or exacerbate depression, which in turn can enhance the sensation of pruritus.Citation77 Injuring the skin by scratching psoriatic plaques can exacerbate the psoriasis. Self-hypnosis can reduce pruritus or itching and give a sense of greater self-control, which in turn can lessen the depression.

Urticaria

In depression-prone individuals, chronic urticaria can initiate or exacerbate depression which can in turn exacerbate pruritus.Citation77 Self-hypnosis can reduce pruritus or itching and give a sense of greater self-control, which can lessen the depression. Hypnosis has resolved some cases of chronic urticaria.Citation25

Vitiligo

In depression-prone individuals, vitiligo can initiate or exacerbate depression, especially in darkly pigmented individuals. Citation80 The prevalence of depression in vitiligo patients was 39% in a recent quality of life study.Citation81 Cognitive-behavioral therapy may help reduce the depression.Citation82 Hypnosis can also help to reframe the patient’s perspective on their depigmented lesions, lessening secondary depression.

Therapeutic options

Conventional pharmacologic psychocutaneous therapies

For the most current information on specific products, check the current Physicians’ Desk Reference,Citation83 package inserts, or other appropriate information source to ascertain dosages, indications and usage, review pharmacokinetics, and note contraindications, warnings, precautions, drug interactions, and adverse reactions. Many psychotropic drugs should be started at a low dose and progressively increased to therapeutic range, then tapered as appropriate. Citation14 Dosages given in the tables are for the average healthy young or middle-aged adult. Lower initial dosages are recommended in the elderly because of slower renal and/or hepatic clearance.

Antidepressants

SSRIs are used in dermatology to treat depression, anxiety, and obsessive–compulsive spectrum disorders associated with skin diseases. Side effects of SSRIs include nausea, diarrhea, insomnia, or sedation.Citation14 SSRIs should be started at low dose and titrated upward. Onset of effects of SSRIs is slow, usually taking three to six weeks (see ).

Table 1 Antidepressants used in dermatologic conditions

Tricylic antidepressants are also used in dermatology for depression and obsessive–compulsive spectrum disorders (see ). Doxepin, which also has antihistaminic properties, is the tricyclic most commonly prescribed by dermatologists. The norepinephrine and dopamine reuptake inhibitor bupropion, an aminoketone antidepressant, is less commonly used (see ).

Antipsychotics

Typical (dopamine receptor antagonist) antipsychotics are used in dermatology for delusional psychoses such as delusions of parasitosis, delusions of bromhidrosis, and Morgellons delusions of fibers (see ). Atypical (serotonin-dopamine antagonist) antipsychotics are often used in dermatology for treatment of resistant cases of obsessive–compulsive spectrum disorders, as a second agent in addition to SSRIs (see ).

Table 2 Antipsychotics and anticonvulsants used in dermatologic conditions

Anticonvulsants

Gamma aminobutyric acid (GABA) elevators are used in dermatology for relief of pain, itching, or paraesthesias in peripheral neuropathies including postherpetic neuralgia (see ).

Anxiolytics

Benzodiazapines are Schedule IV controlled substances because of their potential for abuse and addictive dependence. They tend to be sedating. In dermatology, they are used for pre-procedure anxiety. Generally the short-acting benzodiazapines are preferable for this purpose (see ).

Table 3 Anxiolytics used in dermatologic conditions

The serotonin agonist buspirone is an azaperone. Its advantages are that it is not a controlled substance and is nonsedating. Its disadvantage is that it has a delayed onset of action of about two weeks (see ).

Sedatives

Sedating antihistamines are used extensively in dermatology for pruritus, angioedema, dermatographism, and urticaria. Hydroxyzine and promethazine are also mildly to moderately anxiolytic. In addition, doxepin has antidepressant properties (see ).

Table 4 Sedatives used in dermatologic conditions

Antipruritics

While no really effective antipruritic drugs have been developed, sedating antihistamines may be helpful (see ). Topical antipruritics may also offer relief (see ).

Table 5 Antipruritics used in dermatologic conditions

Complementary pharmacological psychocutaneous therapies

Herbs and supplements

Herbal therapy in dermatology was reviewed by Bedi and ShenefeltCitation84 and use of herbs and supplements in dermatology by Levin and Maibach.Citation85 Further information about individual herbs, their actions, interactions, and adverse effects is available in the PDR for Nonprescription Drugs, Dietary Supplements and Herbs,Citation86 The Complete German Commission E Monographs,Citation87 and in many other textbooks and monographs. Psychoactive herbs and supplements that may have some indirect impact on skin diseases through anxiolytic, antidepressant, or soporific activities are of particular interest in psychosomatic dermatology. Herbal therapy in psychiatry was reviewed by Sarris.Citation88 See the current PDR for Nonprescription Drugs, Dietary Supplements and Herbs for details of their actions, interactions, adverse effects, and literature references.

Antidepressants

Saint John’s wort is approved by the German Commission E for depression. It is helpful in mild to moderate depression but not for severe depression.Citation89 It induces cytochrome P450 which changes the metabolism of a number of other drugs. S-adenosyl-L-methionine (SAMe) is also taken as an antidepressant. A meta-analysis of studies comparing SAMe with controls showed significant clinical improvement with SAMe similar to that of standard SSRI treatment, with fewer side effectsCitation90 (see ).

Anxiolytics

Aromatherapy with lavender oil has been shown to produce a significant reduction in anxiety. Lemon balm has been approved by the German Commission E for nervousness and insomnia. Kava kava has moderate anxiolytic effects, but its use is not recommended because of its potential hepatotoxicity. Magnolia bark has moderate anxiolytic effectsCitation91 and has been used in Japan for a number of years. Passion flower has been approved by the German Commission E for nervousness and insomnia (see ).

Soporifics

Melatonin can produce drowsiness. When it is taken, caution should be used in operating machinery. Valerian has been approved by the German Commission E for insomnia caused by nervousness (see ).

Nonpharmacologic treatments for psychocutaneous disorders

Placebo and nocebo

Expectation forms the basis for the placebo effect. The use of placebo remains controversial.Citation92,Citation93 The patient expectations, the doctor’s expectations, and the doctor-patient relationship can affect the patient’s experience of treatment, reduce pain, and influence outcome. While positive expectations or suggestions can produce positive placebo results, negative expectations or suggestions can produce negative nocebo results.Citation94 Research on the placebo effect illustrates the extent to which the natural healing capacities of individuals can be enhanced and nurtured.Citation95 In some common dermatologic conditions, such as acne and urticaria, the placebo effect is about 30%.Citation96 Those skin disorders higher on the Griesemer scaleCitation67 are more likely to have a significant placebo effect.

Suggestion

Suggestion is the effect that words, intonation, and/or nonverbal cues have by association that can be used to change subjective perceptions, reduce pain, and influence outcome. Suggestion has been used to promote healing since antiquity. BlochCitation97 and Sulzberger and Wolf Citation98 reported on the efficacy of suggestion in treating verruca vulgaris (warts), and that efficacy has since been confirmed numerous times to a greater or lesser degree,Citation99Citation102 but failed to be confirmed in a few studies.Citation103,Citation104 A recent study that showed negative results was criticized for using a negative suggestion of not feeding the warts rather than a positive suggestion about having the warts resolve.Citation105

Cognitive-behavioral methods

Cognitive-behavioral methods alter dysfunctional habits by interrupting and altering dysfunctional thought patterns (cognitions) or actions (behaviors)Citation106 that damage the skin or interfere with dermatologic therapy. Skin diseases responsive to cognitive-behavioral methods include acne excoriée, atopic dermatitis, factitious cheilitis, hyperhidrosis, lichen simplex chronicus, needle phobia, neurodermatitis, onychotillomania, prurigo nodularis, trichotillomania, and urticaria. Adding hypnosis to cognitive-behavioral therapy can facilitate aversive therapy and enhance desensitization and other cognitive-behavioral methods.Citation107

Biofeedback

Biofeedback can enhance the patient’s awareness of tension and help them to relax, improving skin disorders that flare with stress or that have an autonomic nervous system aspect. Biofeedback of GSR can help reduce hyperhidrosis (excess sweating). Biofeedback of skin temperature by temperature-sensitive strip or by thermocouple can be used for relaxation,Citation9 dyshidrosis, and Raynaud’s syndrome.Citation108Citation110 HRV biofeedback can also help reduce the stress response that tends to exacerbate many inflammatory skin disorders. Hypnosis can produce relaxation and enhance the effects produced by biofeedback.Citation107

Hypnosis

Hypnosis has many useful dermatologic applications. Medical hypnotherapy involves guiding the patient into a trance state of narrowed awareness, focused attention, selective wakefulness, and heightened suggestibility for a specific purpose such as relaxation, pain or pruritus reduction, or habit modification. The hypnotic trance compared with the usual waking state has objectively documented differences in regional cerebral blood flowCitation111 and EEGCitation112 patterns. One way that hypnosis may make suggestions more effective is by inhibiting competing thoughts so that the focus can be solely on the suggestion.Citation113 Hypnosis may improve or clear numerous skin disorders. Examples include acne excoriée, alopecia areata, atopic dermatitis, congenital ichthyosiform erythroderma, dyshidrotic dermatitis, erythromelalgia, furuncles, glossodynia, herpes simplex, hyperhidrosis, ichthyosis vulgaris, lichen planus, neurodermatitis, nummular dermatitis, post-herpetic neuralgia, pruritus, psoriasis, rosacea, trichotillomania, urticaria, verruca vulgaris, and vitiligo.Citation7 Generally, high and medium hypnotizables respond better than low hypnotizables, although for many purposes light trance is all that is necessary. Dermatologists should generally not use hypnosis with schizophrenics or others who are not mentally intact. Hypnosis also can reduce anxiety and pain associated with dermatologic procedures. Hypnoanalysis has been successful with reducing erythema nodosum, herpes simplex reactivation, neurodermatitis, neurotic excoriations, rosacea, urticaria, and verrucae (viral warts).Citation25

Conclusion

Skin disorders that produce changes in the appearance of skin, hair, or nails, or changes in sensation can have a major impact on the psyche. Treating the skin disorder effectively often induces psychosocial improvement. The psyche through psychoneuroimmunoendocrine and behavioral mechanisms can in turn have a major impact on skin disorders. Treating the psyche effectively can improve many inflammatory skin disorders. The psychotropic drugs listed above are often somewhat effective by themselves. Adding non-drug psychocutaneous modalities such as biofeedback, cognitive-behavioral methods, hypnosis, or suggestion often synergistically enhance the treatment response. Teaching patients to practice safe stress using these nonpharmacologic methods, supplemented if necessary with anxiolytic standard drugs or herbal alternatives, is important, since many inflammatory skin disorders are worsened by stress. Exercise, meditation, music therapy, progressive relaxation, self-hypnosis, and other stress-reducing methods can enhance overall health and resiliency, as well as achieving improvement in specific skin disorders.

Disclosure

The author reports no conflicts of interest in this work.

References

  • ZaneLTPsychoneuroendocrinimmunodermatology: Pathophysiological mechanisms of stress in cutaneous diseasePsychocutaneous MedicineKooJYMLeeCSNew York, NYMarcel Dekker20036595
  • HarthWGielerUKunirDTauskFAClinical Management in PsychodermatologyBerlin, AGSpringer Verlag2009195208
  • FriedRGNonpharmacologic treatments in psychodermatologyDermatol Clin20022017718511859591
  • JaffaranyMPsychodermatology: A guide to understanding common psychocutaneous disordersPrim Care Companion J Clin Psychiatry2007920321317632653
  • PootFSampognaFOnnisLBasic knowledge in psychodermatologyJ Eur Acad Dermatol Venereol20072122723417243959
  • GriesemerRDEmotionally triggered disease in a dermatological practicePsychiatr Ann197884956
  • ShenefeltPDHypnosis in dermatologyArch Dermatol200013639339910724204
  • UrpeMBuggianiGLottiTStress and psychoneuroimmunologic factors in dermatologyDermatol Clin20052360961716112436
  • ShenefeltPDRelaxation, meditation, and hypnosis for skin disorders and proceduresdeLucaBNMind-Body and Relaxation Research FocusHauppauge, NYNova Science Publishers20084563
  • BarriosAATowards Greater Freedom and Happiness3rd edCulver City, CASelf-Programmed Control Press1985
  • ZuckerTLSamuelsonKWMuenchFGreenbergMAGevirtzRNThe effects of respiratory sinus arrhythmia biofeedback on heart rate variability and posttraumatic stress disorder symptoms: A pilot studyAppl Psychophysiol Biofeedback20093413514319396540
  • PanconesiEPsychosomatic factors in dermatology: Special perspectives for application in clinical practiceDermatol Clin20052362963316112438
  • SeyhanMAkiTKarincaogluYOzcanHPsychiatric morbidity in dermatology patients: Frequency and results of consultationsIndian J Dermatol2006511822
  • LeeCSKooJYMThe use of psychotropic medications in dermatologyKooJYMLeeCSPsychocutaneous MedicineNew York, NYMarcel Dekker2003427451
  • LuckyAWQuantitative documentation of a premenstrual flare of facial acne in adult womenArch Dermatol20041404244
  • HughesHBrownBWLawlisGFFultonJETreatment of acne vulgaris by biofeedback relaxation and cognitive imageryJ Psychosom Res1983271851916224928
  • WillemsonRHaentjensPRoseeuwDVanderlindenJAlexithymia in patients with alopecia areata: Educational background much more important than traumatic eventsJ Eur Acad Dermatol Venereol2009231141114619368614
  • GuptaMAGuptaAKWatteelGNStress and alopecia areata: A psychodermatologic studyActa Derm Venereol Stockholm199777296298
  • WillemsenRVanderlindenJDeconinckARoseeuwDHypnotherapeutic management of alopecia areataJ Am Acad Dermatol20065523323716844504
  • PallantiSLottiTUrpeMPsychoneuroimmunodermatology of atopic dermatitis: From empiric data to the evolutionary hypothesisDermatol Clin20052369570116112446
  • EhlersAStanglerUGielerUTreatment of atopic dermatitis: A comparison of psychological and dermatological approaches to relapse preventionJ Consult Clin Psychol1995636246357673540
  • StewartACThomasSEHypnotherapy as a treatment for atopic dermatitis in adults and childrenBrit J Dermatol19951327787837772485
  • KoblenzerCSDermatitis artifacta: Clinical features and approaches to treatmentAm J Clin Dermatol20004161163
  • KoldysKWMeyerRPBiofeedback training in the therapy of dyshidrosisCutis197924219221157855
  • ShenefeltPDPsychocutaneous hypnoanalysis: Detection and deactivation of emotional and mental root factors in psychosomatic skin disordersAm J Clin Hypn20075013113618030925
  • Buske-KirchenbaumAGeibenAWermkeCPreliminary evidence for herpes labialis recurrence following experimentally induced disgustPsychother Psychosom200170869111244389
  • ScottMJHypnosis in Skin and Allergic DiseasesSpringfield, ILCharles C. Thomas Publishers1960
  • LoweNJGlaserDAEadieNDaggettSKowalskiJWLaiPYBotulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52 week multicenter double-blind, randomized, placebo-controlled study of efficacy and safetyJ Am Acad Dermatol20075660461117306417
  • HölzleETherapie der hyperhidrosisHautarzt199435715 German
  • KorayMDulgerOAkGThe evaluation of anxiety and salivary cortisol levels in patients with oral lichen planusOral Dis2003929830114629330
  • KonukNKocaRAtikLMuhtarSAtasoyNBostanciBPsychopathology, depression and dissociative experiences in patients with lichen simplex chronicusGen Hosp Psychiatry20072923223517484940
  • KoSMUnderdiagnosed psychiatric syndrome, 2: Pathologic skin pickingAnn Acad Med Singapore19992855755910561770
  • LehmanREBrief hypnotherapy of neurodermatitis: A case with four-year follow-upAm J Clin Hypn1978214851696664
  • JarvikallioAHarvimaITNaukkarinenAMast cells, nerves and neuropeptides in atopic dermatitis and nummular eczemaArch Dermatol Res200329517
  • GuarneriFMariniHAn unusual case of perioral dermatitis: Possible pathogenic role of neurogenic inflammationJ Eur Acad Dermatol Venereol20072141041217309479
  • ArckPPausRFrom the brain-skin connection: The neuroendocrine-immune misalliance of stress and itchNeuroimmunomodulation20061334735617709957
  • GriffithsCERichardsHLPsychological influence in psoriasisClin Exp Dermatol20012633834211422186
  • MasmoudiJMaalejIMasmoudiAAlexithymie et psoriasis: Etude cas-temoin a propos de 53 patientsL’Encephalie2009351017 French
  • FortuneDGRichardsHLKirbyBBowcockMainCJGriffithsCEA cognitive-behavioural symptom management programme as an adjunct in psoriasis therapyBr J Dermatol200214645846511952546
  • Kabat-ZinnJInfluence of a mindfulness meditation-based stress reduction intervention on rates of skin clearing in patients with moderate to severe psoriasis undergoing phototherapy (UVB) and photochemo-therapy (PUVA)Psychosom Med1998606256329773769
  • TauskFWhitmoreSEA pilot study of hypnosis in the treatment of patients with psoriasisPsychother Psychosom19996822122510396014
  • Garnis-JonesSPsychological aspects of rosaceaJ Cutan Med Surg1998(Suppl 4)9169677254
  • SinclairRChronic telogen effluvium: A study of 5 patients over 7 yearsJ Am Acad Dermatol2005522 Suppl 1121615692504
  • SteinDJGardnerJPKeuthenNJFranklinMEWalkupJTWoodsDWTrichotillomania, stereotypic movement disorder, and related disordersCurr Psychiatry Rep2007930130217880861
  • BarabaszMTrichotillomania: A new treatmentInt J Clin Exp Hypn1987351461543305378
  • ShertzerCLLookingbillDPEffects of relaxation therapy and hypnotizability in chronic urticariaArch Dermatol19871239139163300566
  • MercanSAltunayIKTaskintunaNOguteenOKayaogluSAtypical antipsychotic drugs in the treatment of delusional parasitosisInt J Psychiatry Med200737293717645196
  • GuptaMAGuptaAKDepression and dermatological disordersKooJYMLeeCSPsychocutaneous MedicineNew York, NYMarcel Dekker2003233249
  • GuptaMASomatization disorders in dermatologyInt Rev Psychiatry200618414716451879
  • ShenefeltPDUsing hypnosis to facilitate resolution of psychogenic excoriations in acne excoriéeAm J Clin Hypn200423924515190729
  • GuptaMAGuptaAKHabermanHFNeurotic excoriations: A review and some new perspectivesCompr Psychiatry1986273813863731771
  • RosenbaumMSAyllonTThe behavioral treatment of neurodermatitis through habit-reversalBehav Res Ther1981193133187271697
  • RothbaumBONinanPTManual for the cognitive-behavioral treatment of trichotillomaniaSteinDJChristensonGAHollanderETrichotillomaniaWashington, DCAmerican Psychiatric Publishing1999263284
  • KearneyCASilvermanWKTreatment of an adolescent with obsessive– compulsive disorder by alternating response prevention and cognitive therapy: An empirical analysisJ Behav Ther Exp Psychiatry19902139472373767
  • IngleseMHaleyHRElewskiBEOnychotillomania: 2 case reportsCutis20047317117415074344
  • KroenkeKSharpeMSykesRRevising the classification of somato-form disorders: Key questions and preliminary recommendationsPsychosomatics20074827728517600162
  • BoweWPLeydenJJCrerandCESarwerDBMargolisDJBody dysmorphic disorder symptoms among patients with acne vulgarisJ Am Acad Dermatol20075722223917498840
  • HarthWHermesBSeikowskiKGielerUNihilodermie in der PsychodermatologieHautarzt200758427434 German17431558
  • WillemsenRRoseeuwDVanderlindenJAlexithymia and dermatology: The state of the artInt J Dermatol20084790391018937652
  • HenningsenPZipfelSHerzogWManagement of functional somatic syndromesLancet200736995651691169217512851
  • HarnackDScheelMMindtAKupschAHeinzAStrohleAPregabalin in patients with antidepressant treastment-resistant somatiform disorders: A case seriesJ Clin Psychopharmacol20072753753917873703
  • WeisshaarEKucenicMJFleischerABPruritus: A reviewActa Derm Venereol2003213Suppl532
  • GuptaMAGuptaAKMedically unexplained cutaneous sensory symptoms may represent somatoform dissociation: An empirical studyJ Psychosom Res20066013113616439265
  • WalcykPJElpernDJBrachioradial pruritus: A tropical dermopathyBrit J Dermatol19861151771803741783
  • GoodkinRWingardEBernhardJDBrachioradial pruritus: Cervical spine disease and neurogenic/neurogenic pruritusJ Am Acad Dermatol20034852152412664013
  • GickCLMirowskiGWKennedyJSBymasterFPTreatment of glossodynia with olanzapineJ Am Acad Dermatol20045146346515337994
  • EisenbergEBameirEBergmanRNotalgia paraesthetica associated with nerve root impingementJ Am Acad Dermatol19973799810009418774
  • EisenbergERiverYShiftrinAKrivoyNAntiepileptic drugs in the treatment of neuropathic painDrugs2007671265128917547471
  • CohenADVanderTMedvendovskyENeuropathic scrotal pruritus: Anogenital pruritus is a symptom of lumbosacral radiculopathyJ Am Acad Dermatol200552616615627082
  • WeichertGEAn approach to the treatment of anogenital pruritusDermatol Ther20041712913314756897
  • KesslerRCBerglundPDemlerOLifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey ReplicationArch Gen Psychiatry20056259360215939837
  • PicardiAAbeniaDMelchiCFPudduPPasquiniPPsychiatric morbidity in dermatological outpatients: An issue to be recognizedBrit J Dermatol200014398399111069507
  • SampognaFPicardiAChrenMMAssociation between poorer quality of life and psychiatric morbidity in patients with different dermatological conditionsPsychosom Med20046662062415272112
  • SchulpisKGeorgalaSPapakonstantinouEDThe psychological and sympatho-adrenal status in patients with cystic acneJ Eur Acad Dermatol Venereol199913242710565626
  • HullPRD’ArcyCAcne, depression, and suicideDermatol Clin20052366567416112443
  • WysowskiDKPittsMBeitzJAn analysis of reports of depression and suicide in patients treated with isotretinoinJ Am Acad Dermatol20014551551911568740
  • GuptaMAGuptaAKSchorkNJDepression modulates pruritus perception: A study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticariaPsychosom Med19945636408197313
  • StoddardFJStroudLMurphyJMDepression in children after recovery from severe burnsJ Burn Care Rehabil1992133403471618879
  • HerbertTBCohenSDepression and immunity: A meta-analytic reviewPsychol Bull19931134724868316610
  • DograSKanawarAJSkin diseases: Psychological and social consequencesIndian J Dermatol200247197201
  • SampognaFRaskovicDGuerraLIdentification of categories at risk for high quality of life impairment in patients with vitiligoBr J Dermatol200815935135918565189
  • PapadopoulosLBorRLeggCCoping with the disfiguring effects of vitiligo: A preliminary investigation into the effects of cognitive-behavioural therapyBr J Med Psychol19997238539610524722
  • PDR Staff2010 Physician’s Desk Reference64th edMontvale, NJ2010
  • BediMKShenefeltPDHerbal therapy in dermatologyArch Dermatol200213823224211843645
  • LevinCMaibachHExploration of “alternative” and “natural” drugs in dermatologyArch Dermatol200213820721111843641
  • PDR Staff2010 PDR for Nonprescription Drugs, Dietary Supplements and Herbs31st edMontvale, NJ2009
  • BlumenthalMThe Complete German Commission E Monographs: Therapeutic Guide to Herbal MedicinesAustin, TXAmerican Botanical Council1998
  • SarrisJHerbal medicines in the treatment of psychiatric disorders: A systematic reviewPhytother Res20072170371617562566
  • LindeKRamirezGMulrowCSt. Johns wort for depression: An overview and meta-analysis of randomized clinical trialsBMJ19963132532588704532
  • BressaGS-adenosyl-L-methionine (SAMe) as antidepressant: Meta-analysis of clinical studiesActa Neurol Scand1994154Suppl714
  • KuribaraHStavinohaWBMaruyamaYBehavioral characteristics of honkiol, an anxiolytic agent present in extracts of magnolia bark, evaluated by an elevated plus-maze test in miceJ Pharm Pharmacol1998508198269720634
  • HrobjartssonAGotzchePCIs the placebo powerless? An analysis of clinical trials comparing placebo with no treatmentN Eng J Med199434415941602
  • SpiegelDKraemerHCarlsonRWIs the placebo powerless? (Letter)N Eng J Med200134512761279
  • SpeigelDPlacebos in practice (Editorial)BMJ200432992792815499085
  • Di BlasiZReillyDPlacebos in medicine: Medical paradoxes need disentangling (Letter)BMJ20053304515626817
  • GuptaMAGuptaAKPsychodermatology: An updateJ Am Acad Dermatol199634103010468647969
  • BlochBÜber die heilung der warzen durch suggestionKlin Wochnschr1927622712275 German
  • SulzbergerMBWolfJThe treatment of warts by suggestionMed Rec1934140552556
  • ObermayerMEGreensonRRTreatment by suggestion of verrucae planae of the facePsychosom Med19491116316418146129
  • UllmanMOn the psyche and warts: I. Suggestion and warts: A review and commentPsychosom Med19592473488
  • DudekSSuggestion and play therapy in the cure of warts in children: A pilot studyJ Nerv Ment Dis196714537424860932
  • SheehanDVInfluence of psychosocial factors on wart remissionAm J Clin Hypn197820160164757317
  • ClarkeGHVThe charming of wartsJ Invest Dermatol196545152114310304
  • StanklerRLA critical assessment of the cure of warts by suggestionPractitioner19671986906946047163
  • FeltBTHallHOlnessKWart regression in children: Comparison of relaxation-imagery to topical treatment and equal time interventionsAm J Clin Hypn199841130138
  • LevensonHPersonsJBPopeKSBehavior therapy and cognitive therapyGoldmanHHReview of General Psychiatry5th edNew York, NYMcGraw-Hill2000472
  • ShenefeltPDBiofeedback, cognitive-behavioral methods, and hypnosis in dermatology: Is it all in your mind?Dermatol Ther20031611412212919113
  • SartiMGBiofeedback in dermatologyClin Dermatol1998167117149949917
  • PanconesiELo stress, le emozioni, la pelleMassonMilan199894
  • FreedmanRRQuantitative measurements of finger blood flow during behavioral treatments for Raynaud’s diseasePsychophysiol1989264437441
  • RainvillePHofbauerRKBushnellMCHypnosis modulates activity in brain structures involved in the regulation of consciousnessJ Cognit Neurosci200214688790112191456
  • FreemanRBarabaszABarabaszMWarnerDHypnosis and distraction differ in their effects on cold pressor painAm J Clin Hypn20004313714811022363
  • BarriosAAUnderstanding Hypnosis: Theory, Scope and PotentialHauppauge NYNova Science Publishers20098790